MDXG profile · all as-reported value updates
MIMEDX GROUP, INC. (MDXG) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Net income | 2016 | 11,974,000 | 390,000 | -11,584,000 | -96.74% | revised comparative figure | 0001376339-17-000042 0001376339-20-000009 | 2 filed observations examined for this concept and period. |
| Operating income | 2016 | 18,446,000 | 884,000 | -17,562,000 | -95.21% | revised comparative figure | 0001376339-17-000042 0001376339-20-000009 | 2 filed observations examined for this concept and period. |
| Stockholders' equity | 2016 | 133,000,000 | 48,067,000 | -84,933,000 | -63.86% | revised comparative figure | 0001376339-17-000042 0001376339-20-000045 | 3 filed observations examined for this concept and period. |
| Operating income | 2022 | -24,971,000 | -14,727,000 | 10,244,000 | +41.02% | revised comparative figure | 0001376339-23-000003 0001376339-25-000009 | 3 filed observations examined for this concept and period. |
| Assets | 2016 | 193,263,000 | 117,274,000 | -75,989,000 | -39.32% | revised comparative figure | 0001376339-17-000042 0001376339-20-000009 | 2 filed observations examined for this concept and period. |
| Operating income | 2021 | -5,035,000 | -7,051,000 | -2,016,000 | -28.59% | revised comparative figure | 0001376339-22-000007 0001376339-24-000009 | 3 filed observations examined for this concept and period. |
| Liabilities | 2016 | 60,263,000 | 69,207,000 | 8,944,000 | +12.92% | revised comparative figure | 0001376339-17-000042 0001376339-20-000009 | 2 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2016 | 34,391,000 | 30,321,000 | -4,070,000 | -11.83% | revised comparative figure | 0001376339-17-000042 0001376339-20-000009 | 2 filed observations examined for this concept and period. |
| Gross profit | 2016 | 212,608,000 | 190,774,000 | -21,834,000 | -10.27% | revised comparative figure | 0001376339-17-000042 0001376339-20-000009 | 2 filed observations examined for this concept and period. |
| Operating cash flow | 2016 | 25,828,000 | 23,849,000 | -1,979,000 | -7.66% | revised comparative figure | 0001376339-17-000042 0001376339-20-000009 | 2 filed observations examined for this concept and period. |
| Revenue | 2021 | 258,615,000 | 242,019,000 | -16,596,000 | -6.42% | revised comparative figure | 0001376339-22-000007 0001376339-24-000009 | 3 filed observations examined for this concept and period. |
| Gross profit | 2021 | 215,332,000 | 202,391,000 | -12,941,000 | -6.01% | revised comparative figure | 0001376339-22-000007 0001376339-24-000009 | 3 filed observations examined for this concept and period. |